THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush

Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years.